000 | 08703nam a22003497a 4500 | ||
---|---|---|---|
003 | NULRC | ||
005 | 20250527182409.0 | ||
008 | 250527b ph ||||| |||| 00| 0 eng d | ||
022 | _a1545-1569 | ||
040 | _cNULRC | ||
245 | _aHospital Pharmacy | ||
260 |
_aLos Angeles : _bSAGE, _cc2022. |
||
300 |
_a192 pages : _billustrations ; _c28 cm. |
||
490 | _vHospital Pharmacy, Volume 57, Issue 1, February 2022 | ||
504 | _aIncludes bibliographical references. | ||
505 | _aThe Clinic and Logistics to Support Health Technology Assessments -- Role of Clinical Pharmacist in COVID-19 Crisis -- Integration of the Codonics Safe Label System® and the Omnicell XT Anesthesia Workstation into Pediatric Anesthesia Practice: Utilizing Technology to Increase Medication Labeling Compliance and Decrease Medication Discrepancies While Maintaining -- Inpatient Antibiotic Costs Associated with Switching from Vancomycin to Daptomycin for Outpatient Parenteral Antibiotic Therapy -- Economic Evaluation of a Pharmacist-Led 5-Day Therapeutic Hold of IV Levothyroxine at an Academic Medical Center -- Impact of Pharmacist Intervention on Medication Adherence and Patient-Reported Outcomes among Depressed Patients in a Private Psychiatric Hospital of Nepal: a randomised controlled trial -- Evaluating Pharmacy Practice in Hospital Settings in Jeddah City, Saudi Arabia: Dispensing and Administration-2019 -- Characterization of Emergency Department Rabies Post-Exposure Prophylaxis Procedures with an Infectious Diseases Clinic Referral Process -- A Pharmacist-Driven Glycemic Control Protocol to Reduce the Rate of Severe Hypoglycemia in High-Risk Patients -- Real-Time Risk Tool for Pharmacy Interventions -- Stability of 4 Intravenous Drug Formulations in Prefilled Syringes Stored Frozen for Up to 60 Days -- An Exploratory Study of a New Vancomycin Eye Drops Formulation for Extemporaneous Compounding -- Impact of a Clinical Pharmacist Intervention Program on the Follow-up of Type-2 Diabetic Patients -- Optimization of Antibiotic Selection in the Emergency Department for Adult Skin and Soft Tissue Infections --Initiation of Buprenorphine/Naloxone on Rates of Discharge Against Medical Advice -- Cost-Effectiveness Analysis of New Beta-Lactam Beta-Lactamase Inhibitor Antibiotics Versus Colistin for the Treatment of Carbapenem-Resistant Infections -- Tramadol and Opioid Prescription Rates in Chronic Kidney Disease Patients Before and After the 2016 Centers for Disease Control and Prevention Opioid Guideline -- The Impact of a Standardized Discharge Process on 30-Day Readmissions for Patients on Outpatient Parenteral Antibiotic Treatment -- Exploring Cost Savings with Specialty Biologic Drugs Administered to Adult Inpatients with Inflammatory Bowel Disease -- Transdermal Patch Administration and Magnetic Resonance Imaging (MRI)-2020 -- A Real-World Comparative Effectiveness Analysis of Thromboprophylactic Use of Enoxaparin Versus Unfractionated Heparin in Abdominal Surgery Patients in a Large U.S. Hospital Database -- Drug Reaction with Eosinophilia and Systemic Symptoms and Agranulocytosis Presenting as Cervical Lymphadenopathy -- Successful Use of Aspirin, Apixaban, and Viscoelastography in a Patient with Severe COVID Disease and Allergy to Porcine Products -- A Scoping Review of the Use of Social and Behavioral Change in Acute Care Antimicrobial Stewardship Initiatives -- Hospital Pharmacists Interventions to Drug-Related Problems at Tertiary Critical Care Pediatric Settings in Jazan, Saudi Arabia -- Patient Education and Sacubitril/Valsartan: A Randomized Comparative Trial -- Impact of the Injectable Opioid Drug Shortage on Analgesia and Sedation Management in the Medical Intensive Care Unit: A Retrospective Cohort Study -- Development of a Pharmacist-Led Opt-Out Cessation Treatment Protocol for Combustible Tobacco Smoking Within Inpatient Settings -- Impact of Ketamine in the Management of Painful Sickle Cell Disease Vaso-Occlusive -- Staff Knowledge Enhancement Program in Hospital Pharmacy: One-Year Experience -- Potential Drug Interactions Between Cannabinoids and Its Derivatives and Oral Anticoagulants. | ||
520 |
_a[Article Title: The Clinic and Logistics to Support Health Technology Assessments/ Francesco Ferrara, Priscilla Santilli, Antonio Vitiello, and Vilma D'Aiuto , p. 5-6]
_uhttps://doi.org/10.1177/0018578720978733 |
||
520 | _a[Article Title: The Clinic and Logistics to Support Health Technology Assessments/ Francesco Ferrara, Priscilla Santilli, Antonio Vitiello, and Vilma D'Aiuto, p. 5-6] | ||
520 |
_a[Article Title: Role of Clinical Pharmacist in COVID-19 Crisis/ Gaurav Tulshiram Damdar, p. 7-10]
Abstract: In late December 2019, a novel coronavirus (2019-nCoV) was first detected in cases of acute respiratory illness in Wuhan, Hubei Province, China, which then rapidly spread globally and become a pandemic infection. The International Committee on Taxonomy of Viruses on 11 February 2020, formally term it as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Likewise, the World Health Organization (WHO) officially named the disease as Coronavirus Disease 2019 (COVID-19). The WHO has now declared as “public health emergency of international concern” and a global pandemic. _b _uhttps://doi.org/10.1177/001857872098542 |
||
520 |
_a[Article Title: Integration of the Codonics Safe Label System® and the Omnicell XT Anesthesia Workstation into Pediatric Anesthesia Practice: Utilizing Technology to Increase Medication Labeling Compliance and Decrease Medication Discrepancies While Maintaining/ James Joseph Thomas, Ferras Bashqoy, John T. Brinton, Patrick Guffey, and Myron Yaster, p. 11-16]
Abstract: _b _uhttps://doi.org/10.1177/0018578720985429 |
||
520 |
_a[Article Title: Inpatient Antibiotic Costs Associated with Switching from Vancomycin to Daptomycin for Outpatient Parenteral Antibiotic Therapy/ James Beardsley, Swetangini Patel, Corbin Cook, Brandi Pierce, James Johnson, Christopher Ohl, and Vera Luther, p.17-19] _uhttps://doi.org/10.1177/0018578720970464 |
||
520 |
_a[Article Title: Economic Evaluation of a Pharmacist-Led 5-Day Therapeutic Hold of IV Levothyroxine at an Academic Medical Center/ Blake T. Barlow, Russel J. Roberts, Kelly Newman, Sarah K. Harrison, and Jonathan H. Sin, p. 20-25] _b _uhttps://doi.org/10.1177/0018578720970457 |
||
520 |
_a[Article Title: Impact of Pharmacist Intervention on Medication Adherence and Patient-Reported Outcomes among Depressed Patients in a Private Psychiatric Hospital of Nepal: a randomised controlled trial/ Nirmal Raj Marasine, Sabina Sankhi, and Rajendra Lamichhane, p. 26-31] _b _uhttps://doi.org/10.1177/0018578720970465 |
||
520 |
_a[Article Title: IEvaluating Pharmacy Practice in Hospital Settings in Jeddah City, Saudi Arabia: Dispensing and Administration-2019/ Ahmed Altyar, Samaher Abdullah Sadoun, Sarah Sultan Aljohani, and Rahaf Saad Alradadi, p. 32-37] _b _uhttps://doi.org/10.1177/0018578720970470 |
||
520 |
_a[Article Title: Characterization of Emergency Department Rabies Post-Exposure Prophylaxis Procedures with an Infectious Diseases Clinic/ Jessica J. Frederickson, Alexandra K. Monroe, Gregory A. Hall, and Kyle A. Weant, p. 38-44] _uhttps://doi.org/10.1177/0018578720973889 |
||
520 |
_a[Article Title: A Pharmacist-Driven Glycemic Control Protocol to Reduce the Rate of Severe Hypoglycemia in High-Risk Patients/ Colleen A. Cook, Victor Vakayil, Kyle Pribyl, Derek Yerxa, John Kriz, Angie Case, Steven Meisel, Tammy Ho, and James V. Harmon , p. 45-51] _b _uhttps://doi.org/10.1177/0018578720973891 |
||
520 |
_a[Article Title: Real-Time Risk Tool for Pharmacy Interventions/ Hanh L. Nguyen, Kristin S. Alvarez, Boryana Manz, Arun Nethi, Varun Sharma, Venkatraghavan Sundaram, and Manjula Julka, p. 52-60] _b _uhttps://doi.org/10.1177/0018578720973884 |
||
520 |
_a[Article Title: Stability of 4 Intravenous Drug Formulations in Prefilled Syringes Stored Frozen for Up to 60 Days/ Michael C. Storm, Joyce E. Broyles, Oscar R. Herrera, and Richard A. Helms, p. 61-68] _b _uhttps://doi.org/10.1177/001857872097388 |
||
520 |
_a[Article Title: An Exploratory Study of a New Vancomycin Eye Drops Formulation for Extemporaneous Compounding/ Pang Chen, Zin Mar, Anthony Giannetti, Susan Hughes, Justine Gilbert, and Fang Zhao , p. 69-75] _b _uhttps://doi.org/10.1177/001857872097388 |
||
520 |
_a[Article Title: Impact of a Clinical Pharmacist Intervention Program on the Follow-up of Type-2 Diabetic Patients/ Abdel-Hameed I. Ebid, Mohamed A. Mobarez, Ramadan A. Ramadan, and Mohamed A. Mahmoud, p. 76-82] _b _uhttps://doi.org/10.1177/0018578720973881 |
||
942 |
_2lcc _cSER _n0 |
||
999 |
_c22550 _d22550 |